Fund Holdings — Caligan Partners LP

Total Portfolio Value:
$296.52M
Total Bought:
$82.78M
Total Sold:
$9.07M
Net Transaction:
+$73.72M
Notable People:
Caligan Partners Gp Llc
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Liquidia Corporation(LQDA)9,243,62710,360,945+1,117,318$58.60M$124.64M42.03%+$66.04M
Alimera Sciences Inc16,835,15416,835,1540$52.19M$72.73M24.53%+$20.54M
Anika Therapeutics Inc1,081,3601,081,3600$20.15M$24.50M8.26%+$4.36M
Exelixis, Inc.(EXEL)910,730910,7300$19.90M$21.85M7.37%+$1.95M
Standard BioTools Inc.(LAB)7,622,4137,042,413-580,000$22.10M$15.56M5.25%-$6.54M
Evolus, Inc.(EOLS)1,683,8361,317,856-365,980$15.39M$13.88M4.68%-$1.51M
Agios Pharmaceuticals, Inc.(AGIO)4,833441,833+437,000$119.6K$9.84M3.32%+$9.72M
Y-Mabs Therapeutics Inc23,3211,048,425+1,025,104$127.1K$7.15M2.41%+$7.02M
Verona Pharma PlcADS183,064183,0640$2.98M$3.64M1.23%+$655.4K
Adma Biologics Inc597,513473,087-124,426$2.14M$2.14M0.72%-$744
Societal Cdmo Inc1,689,7681,689,7680$794.2K$592.3K0.20%-$201.9K
VERRICA PHARMACEUTICALS INCCOM(VRCA)259,5930-259,593$1.01M$0—-$1.01M
Page 1 of 1